Issue 4, 2023

Dimeric polyphenols to pave the way for new antimalarial drugs

Abstract

Because of the threat of resistant Plasmodium sp., new orally active antimalarials are urgently needed. Inspired by the structure of ellagic acid, exhibiting potent in vivo and in vitro antiplasmodial effects, polyphenolic structures possessing a similar activity-safety profile were synthesized. Indeed, most exhibited a marked in vitro effect (IC50 < 4 μM) on resistant P. falciparum, without any detrimental effects reported during the toxicity assays (hemolysis, cytotoxicity, in vivo). In addition, they possessed a greater hydrosolubility (from 7 μM to 2.7 mM) compared to ellagic acid. Among them, 30 is the most promising for antimalarial purposes since it displayed a significant parasitaemia reduction after oral administration in mice (50 mg kg−1) compared to the orally ineffective ellagic acid. In conclusion, our investigations led to the identification of a promising scaffold, which could bring new insights for malaria treatment.

Graphical abstract: Dimeric polyphenols to pave the way for new antimalarial drugs

Supplementary files

Article information

Article type
Research Article
Submitted
25 Oct 2022
Accepted
07 Feb 2023
First published
10 Feb 2023

RSC Med. Chem., 2023,14, 715-733

Dimeric polyphenols to pave the way for new antimalarial drugs

G. Degotte, H. Pendeville, C. Di Chio, R. Ettari, B. Pirotte, M. Frédérich and P. Francotte, RSC Med. Chem., 2023, 14, 715 DOI: 10.1039/D2MD00392A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements